InvestorsHub Logo
Followers 2
Posts 38
Boards Moderated 0
Alias Born 12/12/2020

Re: None

Friday, 01/28/2022 9:28:21 AM

Friday, January 28, 2022 9:28:21 AM

Post# of 323
Gilead C47 drug trial halted FDA by. Positive news on Pelareorep with same combo!!!!!!!!@



- 15 Dec 2021--- Treatment with intravenous pelareorep plus azacitidine reduced tumor burden ------------------------------------------------------

26 Jan 2022--- Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Azacitidine.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCY News